KRONOXSpecialty Chemicals
Kronox Lab Science Ltd — Cash Flow Statement
₹97.02
-4.42%
Kronox Lab Science Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Capital Expenditure | -3.10 Cr | -12.27 Cr | -8.41 Cr | -3.80 Cr | — |
| End Cash Position | 3.04 Cr | 2.59 Cr | 3.56 Cr | 2.81 Cr | — |
| Other Cash Adjustment Outside Changein Cash | -1000.00 | — | — | 10000.00 | — |
| Beginning Cash Position | 2.59 Cr | 2.48 Cr | 2.81 Cr | 2.05 Cr | — |
| Changes In Cash | 0.45 Cr | 0.10 Cr | 0.75 Cr | 0.76 Cr | — |
| Financing Cash Flow | -1.85 Cr | 0.00 | -13.40 Cr | -0.67 Cr | — |
| Net Other Financing Charges | 1000.00 | — | -0.80 Cr | -0.89 Cr | -0.82 Cr |
| Interest Paid Cff | 0.00 | 0.00 | -0.09 Cr | -0.41 Cr | — |
| Cash Dividends Paid | -1.85 Cr | — | — | — | — |
| Common Stock Dividend Paid | -1.85 Cr | 0.00 | — | — | — |
| Investing Cash Flow | -28.39 Cr | -17.31 Cr | -5.52 Cr | -7.60 Cr | — |
| Interest Received Cfi | 1.78 Cr | 1.02 Cr | 0.42 Cr | 0.32 Cr | — |
| Dividends Received Cfi | 3000.00 | 3000.00 | 0.00 | 0.00 | — |
| Net Investment Purchase And Sale | -27.07 Cr | -6.06 Cr | 2.45 Cr | -4.20 Cr | — |
| Net PPE Purchase And Sale | -3.10 Cr | -12.27 Cr | -8.39 Cr | -3.71 Cr | — |
| Sale Of PPE | 0.00 | 0.00 | 0.02 Cr | 0.08 Cr | 0.08 Cr |
| Purchase Of PPE | -3.10 Cr | -12.27 Cr | -8.41 Cr | -3.80 Cr | — |
| Operating Cash Flow | 30.70 Cr | 17.42 Cr | 19.66 Cr | 9.02 Cr | — |
| Taxes Refund Paid | -8.88 Cr | -7.35 Cr | -5.79 Cr | -4.79 Cr | — |
| Change In Working Capital | 5.44 Cr | -4.38 Cr | 1.97 Cr | -6.88 Cr | — |
| Change In Other Current Liabilities | 0.35 Cr | 0.46 Cr | -60000.00 | -70000.00 | — |
| Change In Other Current Assets | 3.78 Cr | -3.60 Cr | 0.09 Cr | -50000.00 | — |
| Change In Payable | 0.67 Cr | -2.07 Cr | -3.71 Cr | 5.50 Cr | — |
| Change In Inventory | 2.88 Cr | -0.08 Cr | -1.66 Cr | -2.02 Cr | — |
| Change In Receivables | -2.24 Cr | 0.91 Cr | 7.26 Cr | -10.35 Cr | — |
| Other Non Cash Items | -1.78 Cr | -1.02 Cr | -0.59 Cr | 0.09 Cr | — |
| Provisionand Write Offof Assets | 0.00 | -24000.00 | -70000.00 | -80000.00 | — |
| Depreciation And Amortization | 1.38 Cr | 1.29 Cr | 1.50 Cr | 2.03 Cr | — |
| Depreciation | 1.38 Cr | 1.29 Cr | 1.50 Cr | 2.03 Cr | — |
| Pension And Employee Benefit Expense | 0.27 Cr | 0.27 Cr | 0.28 Cr | 0.25 Cr | — |
| Gain Loss On Investment Securities | -3000.00 | -3000.00 | -0.01 Cr | -0.03 Cr | — |
| Net Income From Continuing Operations | 34.27 Cr | 28.61 Cr | 22.33 Cr | 18.36 Cr | — |
| Free Cash Flow | 27.59 Cr | 5.14 Cr | 11.25 Cr | 5.22 Cr | — |
| Net Other Investing Changes | — | -1000.00 | 0.90 Cr | 0.60 Cr | -0.75 Cr |
| Net Common Stock Issuance | — | — | -12.50 Cr | 0.00 | -5.88 Cr |
| Common Stock Payments | — | — | -12.50 Cr | 0.00 | -5.88 Cr |
| Net Issuance Payments Of Debt | — | — | 0.00 | 0.63 Cr | -0.01 Cr |
| Net Long Term Debt Issuance | — | — | 0.00 | 0.63 Cr | -0.01 Cr |
| Long Term Debt Issuance | — | — | 0.00 | 0.63 Cr | — |
| Sale Of Investment | — | — | 1.55 Cr | — | — |
| Repurchase Of Capital Stock | — | — | -12.50 Cr | 0.00 | -5.88 Cr |
| Issuance Of Debt | — | — | 0.00 | 0.63 Cr | — |
| Purchase Of Investment | — | — | — | -4.80 Cr | -0.91 Cr |
| Long Term Debt Payments | — | — | — | — | -0.01 Cr |
| Repayment Of Debt | — | — | — | — | -0.01 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Kronox Lab Science Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.